research use only

THZ2 CDK inhibitor

Cat.No.S7969

THZ2, a THZ1 analog, is a selective inhibitor of CDK7 with IC50 of 13.9 nM. This compound efficiently suppresses the clonogenic growth of TNBC cells with IC50 of ~10 nM.
THZ2 CDK inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 566.05

Quality Control

Batch: S796901 DMSO]100 mg/mL]false]Water]˂1 mg/mL]false]Ethanol]˂1 mg/mL]false Purity: 99.65%
99.65

Chemical Information, Storage & Stability

Molecular Weight 566.05 Formula

C31H28ClN7O2

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 1604810-84-5 -- Storage of Stock Solutions

Synonyms N/A Smiles CN(C)CC=CC(=O)NC1=CC=CC(=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (176.66 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : ˂1 mg/mL

Ethanol : ˂1 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
CDK7 [1]
(Cell-free assay)
13.9 nM
In vitro

THZ2 selectively targets CDK7 and potently inhibits the growth of triple-negative but not ER/PR+ breast cancer cells. This compound at low nanomolar doses also efficiently suppresses the clonogenic growth of TNBC cells.[1]

In vivo

THZ2 is well tolerated in nude mice. The growth rate of tumors in mice treated with this compound is markedly reduced as compared to that of control tumors, demonstrating an anti-tumor activity of this chemical. Both acute and chronic exposure to it significantly reduces CTD phosphorylation of RNAPII at all three phosphorylation sites (S2, S5, and S7), indicating that CDK7 is efficiently targeted in the tumor cells. Compared to vehicle-treated tumors, tumor tissues isolated from mice treated with this agent has reduced proliferation and increased apoptosis. It is able to efficiently reduce tumor cell proliferation and induce cell death in vivo.[1]

References

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map